United States

EMEA equity capital markets houses are finding a receptive audience for accelerated share sales as stockmarket indices hit new highs. But despite this, IPOs still face difficulties.

YX Asset Recovery, a Chinese consumer debt restructuring specialist, has started gauging investor appetite for an IPO of around $200m on the The New York Stock Exchange.

The Province of Alberta came to market on Tuesday for a five year dollar global bond, paving the way for the Swedish Export Credit Corporation (SEK), which announced that it will hit the three year bucket on Wednesday.

Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.

In this round-up, the US and China held another round of phone calls on trade last Friday, China officially launched the 5G mobile network and the rise in Caixin Purchasing Managers’ Index (PMI) was at odds with the slump in the official PMI.

In this round-up, the Chinese Communist Party (CCP) said it will strengthen the country’s ideological and institutional design, the Chilean government called off a planned Apec meeting and the State Administration for Market Regulation (SAMR) and the People’s Bank of China released a list of certified fintech products.

UBS lets go of ECM bankers — Bank of America’s Coben to return after Twitter investigation — Macquarie closes cash equities business in Europe and US

HSBC is planning to allocate capital away from lower return operations, including the global banking and markets (GBM) division in certain regions, as interim chief executive Noel Quinn revealed disappointing third quarter results on Monday.

Dollar volumes proved higher than expected as the US investment grade market roared back to life following earnings blackouts, with a string of front-loaded deals ahead of the Fed’s meeting on Wednesday.

French auto-manufacturer PSA Group, which owns Peugeot, and Fiat Chrysler Automobile's (FCA) decision to explore a merger to create the world’s fourth largest car company is an important marker for an industry facing an uncertain future as sustainability and the environment become global priorities.

Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has entered the US private placement (US PP) market, according to sources, in a debut set to test institutional appetite for the sector.

Chinese biopharmaceutical firm I-Mab has set the ball rolling for a potential $100m Nasdaq IPO, having filed a prospectus with the US regulator on Tuesday.